| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.095 | 0.09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.099 | 0.07 |